Table 3 Linear stepwise regression analysis of ICF-based limitations by the Ménière’s disease with EQ-5D VAS and EQ-5D index values as outcome variables
From: Impact evaluation and association with EuroQol 5D health-related utility values in Ménière’s disease
Variable | VAS model, r = 0.293 | EQ-5D index value model, r = 0.293 | ||||
|---|---|---|---|---|---|---|
Coeff | S.E. | P | Coeff | S.E. | P | |
Constant | 69.1 | 1.7 | <0.001 | 0.78 | 0.02 | <0.001 |
Vertigo | −7.6 | 2.9 | 0.010 | n.s | n.s | 0.168 |
Hearing | 6.9 | 3.9 | 0.012 | n.s | n.s | 0.192 |
Diet | 0.7 | 4.2 | 0.022 | n.s | n.s | 0.996 |
Nausea | n.s | n.s | 0.543 | −0.13 | 0.07 | 0.011 |
Drugs | n.s | n.s | 0.161 | 0.22 | 0.05 | 0.003 |